Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:DPLO

Diplomat Pharmacy (DPLO) Stock Price, News & Analysis

Diplomat Pharmacy logo

About Diplomat Pharmacy Stock (NYSE:DPLO)

Advanced Chart

Key Stats

Today's Range
$4.00
$4.01
50-Day Range
$4.00
$4.00
52-Week Range
$2.43
$14.46
Volume
744,968 shs
Average Volume
545,194 shs
Market Capitalization
$304 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DPLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diplomat Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

DPLO Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

DPLO Stock Analysis - Frequently Asked Questions

Diplomat Pharmacy Inc (NYSE:DPLO) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($2.35) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $2.15. The firm's revenue for the quarter was down 5.3% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diplomat Pharmacy investors own include Bausch Health Cos (BHC), Gilead Sciences (GILD), Bristol Myers Squibb (BMY), Cara Therapeutics (CARA), Cannabis Sativa (CBDS), CVS Health (CVS) and Jazz Pharmaceuticals (JAZZ).

Company Calendar

Last Earnings
11/12/2019
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug Stores & Proprietary Stores
Sub-Industry
N/A
Current Symbol
NYSE:DPLO
CIK
1610092
Fax
N/A
Employees
2,335
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.20
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$302.27 million
Net Margins
-12.47%
Pretax Margin
N/A
Return on Equity
-12.15%
Return on Assets
-3.05%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
0.55
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$5.49 billion
Price / Sales
0.06
Cash Flow
$4.60 per share
Price / Cash Flow
0.87
Book Value
$6.24 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
76,000,000
Free Float
N/A
Market Cap
$304 million
Optionable
Optionable
Beta
0.82
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:DPLO) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners